1. Max Planck Institute for Molecular Biomedicine, Münster
2. Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg
3. Max Planck Institute for Physiological and Clinical Research, Bad Nauheim Germany
4. Division of Biochemistry, Katholieke Universiteit Leuven, Leuven, Belgium
5. IRCM, Montreal, Quebec, Canada